Q4 2021 · 13F-HR
Antipodean Advisors LLCholdings as filed
Filed 2022-02-14 · accession 0000919574-22-000953
$243,580
Reported value
6
Positions
2021-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 146869102 | CVNA | CARVANA CO | $93,875 | 38.5% | 405,000 | Common | SOLE |
| 81141R100 | SE | SEA LTD | $78,299 | 32.1% | 350,000 | Common | SOLE |
| 14161W105 | CDLX | CARDLYTICS INC | $42,218 | 17.3% | 638,800 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $15,760 | 6.47% | 1,000,000 | Common | SOLE |
| G21810109 | CLVT | CLARIVATE PLC | $8,820 | 3.62% | 375,000 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $4,608 | 1.89% | 600,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.